|
|
|
Pharmaceutical Manufacturing and Packing Sourcer
|
Packaging insulation is vital to combat energy losses during transportation and storage as it reduces unwanted heat flow between the product and the environment. In particular, thermal materials act as a barrier, preventing heat transfer between objects of differing temperatures. The same principle works for packaging containers and buildings. Thermal insulated packaging is indispensable for the safe transit of biodegradable and highly perishable items, such as medicines, biotech, electronics, horticulture and chemicals – the purpose of which is to avoid deterioration in quality and efficacy. Many different types of these materials are available on the market today and companies select their preferred option based on cost, weight, effectiveness and environmental factors.
Preferable Characteristics
The objective of adequate insulation is to effectively maintain product temperatures within permissible range and reduce the deterioration rate of a product during transit. Depending upon the application, a good material has the following relevant characteristics:
- High resistance to heat transfer by conduction, convection or radiation
- Low cost
- Low weight
- Low moisture susceptibility
- Ease of fabrication and transportation
- Durability
- Mechanical strength
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
Jean Bédard, MBA, is former President and Chief Executive Officer at Infitrak. He has more than 20 years of experience in developing and managing companies in the highly regulated pharma, life sciences and food sectors. He has acted as the Vice President in business development for a world-class company specialising in regulatory compliance, validation and process engineering for the pharma and biotech sectors. Jean has also acted as CEO of a large cold chain company, where he was responsible for managing over 1,000 individual projects. Additionally, he also holds an MBA in bio-industries management from the UQAM, Canada.
Kevin Kohleriter is President at The MarketBurst Group and Consultant for Mesa Labs. His former roles in senior management at Texas Instruments, Alcatel, McAfee and ShockWatch provide him with the experience to give strategy to clients and write about a variety of technology-related topics. He has published over 50 articles and papers in the cold chain market. Kevin graduated from Texas Tech University with a BA in technical communications and has an MBA from the University of Dallas.
|
|
|
|
|
|
 |
News and Press Releases |
 |
Vetter continues its successful performance at the 2021 CMO Leadership Awards
Ravensburg, Germany, February 18, 2021 – Vetter, a globally
operating Contract Development and Manufacturing Organization (CDMO),
was granted the 2021 CMO Leadership Awards in five core categories –
quality, expertise, compatibility, capabilities, and service. The award,
now in its tenth year, was given by the leading trade press
publication, Life Science Leader. Vetter was also the recipient of the
award in a variety of categories in previous years.
More info >> |
|
 |
White Papers |
 |
|
Clinical Trial-Specific Travel Programs as a Patient Retention Tool
For many patients, participating in a clinical trial is a major endeavor. Depending on the protocol requirements, study visits can be exhausting. There are a number of reasons why a patient may choose to participate in a trial only to drop out. Conversely, there are several approaches to proactively try to prevent this from happening. There are various methods professionals implement for patient retention. This white paper explores patient travel services as one patient retention strategy.
More info >> |
|
|
